Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer

Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer

Identification of predictive biomarkers for ovarian cancer (OC) treatment, particularly in the platinum-resistant/refractory setting, is highly relevant for clinical management. E-cadherin, vimentin, and osteopontin (OPN) are proteins associated with tumor microenvironment (TME) remodelling that pla...

Full description

Bibliographic Details
Main Authors: Isabel J. Dionísio de Sousa, Durval S. Marques, Catarina Príncipe, Raquel V. Portugal, Sule Canberk, Hugo Prazeres, José M. Lopes, Etel R. P. Gimba, Raquel T. Lima, Paula Soares
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Diagnostics
Subjects:
ovarian cancer
tumor microenvironment
E-cadherin
vimentin
osteopontin
osteopontin-c
Online Access:https://www.mdpi.com/2075-4418/10/8/525

Similar Items

Similar Items